Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1617 1623 1627
This examiner grants 44% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 19535590 | FATTY ACID COMPOSITIONS | Final Rejection | Fera Diagnostics and Biologicals Corp. |
| 19198257 | FATTY ACID COMPOSITIONS | Final Rejection | Fera Diagnostics and Biologicals Corp. |
| 18134539 | METHOD OF PREVENTING KIDNEY INJURY DISRUPTION OF INTESTINAL LYMPHATICS | Final Rejection | Vanderbilt University |
| 18566259 | SUBSTITUTED INDOLE COMPOUNDS AND METHODS OF USE THEREOF | Non-Final OA | NOVARTIS PHARMA AG |
| 18285409 | COMPOSITION FOR INCREASING RED BLOOD CELLS AND/OR HEMOGLOBIN | Non-Final OA | SUNTORY HOLDINGS LIMITED |
| 18260721 | USP13 INHIBITORS AND METHODS OF USE THEREOF | Non-Final OA | GEORGETOWN UNIVERSITY |
| 18272176 | METHODS FOR OPTIMIZING CFTR-MODULATOR THERAPY | Non-Final OA | Children's Hospital Medical Center |
| 18549622 | BELVARAFENIB FOR USE IN TREATMENT OF BRAIN CANCERS | Non-Final OA | Hanmi Pharm. Co., Ltd. |
| 18328682 | ADJUNCTIVE THERAPY FOR DEPRESSION | Final Rejection | ANeuroTech BV |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy